Dae-Seok Kim

发表

Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells.

Miao Sun, W. Kraus, W. Kraus, 2015, Molecular cell.

Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance

W. Kraus, Dae-Seok Kim, Cristel V. Camacho, 2021, Experimental & molecular medicine.

Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.

Soo-Youl Kim, S. Suh, K. Lee, 2009, Cancer letters.

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.

Soo-Youl Kim, Dae-Seok Kim, K. Park, 2009, Cancer letters.

Proteomic analysis of high‐molecular‐weight protein polymers in a doxorubicin‐resistant breast‐cancer cell line

Soo-Youl Kim, Dae-Seok Kim, K. Park, 2007, Proteomics. Clinical applications.

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

Soo-Youl Kim, Kyung-Hee Kim, B. Yoo, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-KB Inactivation

Soo-Youl Kim, B. Nam, Dae-Seok Kim, 2006 .

Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21.

V. Malladi, W. Kraus, Anusha Nagari, 2019, Molecular cell.

PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity.

Yonghao Yu, W. Kraus, Xin Luo, 2017, Molecular cell.

Transglutaminase 2 Mediates Polymer Formation of I-κBα through C-terminal Glutamine Cluster*

Soo-Youl Kim, Dae-Seok Kim, In-Hoo Kim, 2006, Journal of Biological Chemistry.

Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues.

Soo-Youl Kim, Dae-Seok Kim, K. Park, 2009, Frontiers in bioscience.

I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.

Soo-Youl Kim, C. Bae, Dae-Seok Kim, 2010, Biochemical and biophysical research communications.

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster.

Soo-Youl Kim, Dae-Seok Kim, In-Hoo Kim, 2006, The Journal of biological chemistry.

Adipocyte mesenchymal transition contributes to mammary tumor progression

D. Strand, P. Scherer, Qingzhang Zhu, 2022, Cell reports.

Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors.

Soo-Youl Kim, Dae-Seok Kim, K. Park, 2009, Frontiers in bioscience.

A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.

Soo-Youl Kim, R. Voll, Dae-Seok Kim, 2008, Journal of molecular biology.

Obesity, Diabetes, and Increased Cancer Progression

P. Scherer, Dae-Seok Kim, 2021, Diabetes & metabolism journal.

PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis

W. Kraus, W. Kraus, Dae-Seok Kim, 2020, Genes & development.

New Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases

W. Kraus, W. Kraus, Dae-Seok Kim, 2015, Chemical reviews.

Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.

Changsun Choi, S. Oh, Dae-Seok Kim, 2010, Biochemical and biophysical research communications.

Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers

Srinivas Malladi, W. Kraus, Shrikanth S. Gadad, 2022, bioRxiv.

Specific Binding of snoRNAs to PARP-1 Promotes NAD+-Dependent Catalytic Activation.

W. Kraus, Dae-Seok Kim, Dan-Xia Huang, 2020, Biochemistry.

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer

S. Jang, Seong-Yeol Park, B. Nam, 2011, Molecular Cancer.

TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.

S. Oh, Dae-Seok Kim, K. Park, 2011, Frontiers in bioscience.

a depletion by transglutaminase 2 and l-calpain occurs in parallel with the ubiquitin – proteasome pathway

C. Bae, Dae-Seok Kim, B. Han, 2010 .

Proteomic analysis of high‐molecular‐weight protein polymers in a doxorubicin‐resistant breast‐cancer cell line

Dae-Seok Kim, K. Park, Sung-Soo Park, 2007, Proteomics. Clinical applications.

Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance

W. Kraus, Dae-Seok Kim, Cristel V. Camacho, 2021, Experimental & Molecular Medicine.